Advances in the diagnosis and treatment of immune checkpoint inhibitor-related pneumonitis
With the rapid advancements of modern medicine,immunotherapy is now being used to treat a variety of tumors,providing a new treatment option beyond conventional treatments like chemotherapy and radiation.Nonetheless,with the widespread use of immunotherapy,there has been a gradual increase in immune checkpoint inhibitor-related adverse events.One such adverse event is immune checkpoint inhibitor-related pneumonitis(CIP).It has low incidence,potential lethality,a lack of specific clinical manifestations,and difficulties in clinical diagnosis.In this article,we hope to offer a useful resource for the prompt diagnosis and efficient treatment of CIP by providing a thorough review of the latest research findings on the epidemiology,pathophysiology,risk factors,clinical manifestations,diagnosis,and treatment of CIP.
NETL
NSTL
万方数据
